Showing results (361-370 of 781) with videos related to
Sort By:
Pageof 79
Annals of Internal Medicine|December 19, 2007
Meta-analysis: vitamin D compounds in chronic kidney diseaseSuetonia C Palmer, David O McGregor, Petra Macaskill, et al.Transplantation|October 19, 2018
Informative for Decision Making? The Spectrum and Consistency of Outcomes After Living Kidney Donation Reported in Trials and Observational StudiesCamilla S Hanson, Benedicte Sautenet, Jonathan C Craig, et al.Clinical Kidney Journal|September 15, 2023
Partnering with patients and caregivers to enrich research and care in kidney disease: values and strategiesRosanna Cazzolli, Amanda Sluiter, Chandana Guha, et al.The Journal of Pediatrics|June 27, 2013
Quality of life of young adults and adolescents with chronic kidney diseaseAllison Tong, Germaine Wong, Steve McTaggart, et al.Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 7, 2018
Unexpected donor-derived infectious transmissions by kidney transplantation: A systematic reviewRashmi Shingde, L Ines Habachou, Vaishnavi Calisa, et al.Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 17, 2021
Stakeholder perspectives on the implementation and impact of Indigenous health interventions: A systematic review of qualitative studiesShingisai Chando, Allison Tong, Martin Howell, et al.Transplantation|August 2, 2016
The Impact of Total Ischemic Time, Donor Age and the Pathway of Donor Death on Graft Outcomes After Deceased Donor Kidney TransplantationGermaine Wong, Armando Teixeira-Pinto, Jeremy R Chapman, et al.Journal of the American Society of Nephrology : JASN|May 2, 2009
Association of CKD and cancer risk in older peopleGermaine Wong, Andrew Hayen, Jeremy R Chapman, et al.BMJ (Clinical Research Ed.)|June 25, 2009
Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial dataKaty J L Bell, Andrew Hayen, Petra Macaskill, et al.Kidney International|May 24, 2013
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patientsYeoungjee Cho, David W Johnson, Sunil V Badve, et al.Pageof 79